ArticleBMC public health2026
UK dementia prevention policies and initiatives across the life-course: a scoping review (2009-2024).
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDementia is a growing public health challenge, with up to 45% of cases potentially preventable through modification of life-course risk factors. Although UK policies increasingly recognise prevention, the extent to which strategies are effectively implemented, evaluated, and equitably delivered remains unclear. This study aimed to systematically map and critically evaluate UK dementia-prevention strategies, with a focus on their reach, implementation, life-course coverage, and equity.
methodsA scoping review was conducted in accordance with PRISMA-ScR guidelines. We searched PubMed, Scopus, and Web of Science, alongside grey literature sources including government, NHS, and non-governmental organisation reports, to identify dementia-prevention strategies implemented in the UK between 2009 and 2024. Eligible records included national policies, public health campaigns, clinical initiatives, and professional resources addressing modifiable dementia risk factors. Strategies were analysed using the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, Maintenance), with additional consideration of life-course targeting and equity.
resultsTwenty-three strategies were identified across policy, campaign, clinical, and professional domains. Dementia prevention was frequently embedded within broader non-communicable disease agendas rather than addressed through dedicated policies. Government-led campaigns (e.g. One You, Couch to 5 K) achieved high population reach but lacked explicit brain-health framing, while non-governmental campaigns (e.g. Reduce Your Risk, Think Brain Health) provided dementia-specific messaging but operated at smaller scale with limited evaluation. Clinical and professional initiatives (e.g. NICE NG16, NHS Health Checks) demonstrated variable uptake and inconsistent implementation. Across all domains, effectiveness and long-term maintenance were poorly evidenced due to limited follow-up and weak monitoring approaches. Most strategies focused on mid-life populations, with minimal attention to early- or late-life prevention, and no reporting on socioeconomic and ethnic inequalities.
conclusionsUK dementia-prevention efforts remain fragmented, under-evaluated, and insufficiently targeted across the life-course and many population groups. Strengthening prevention will require a dedicated national strategy with measurable indicators, integration of risk-reduction into routine healthcare and community settings, expansion of early-life interventions, and implementation of standardised evaluation frameworks with equity monitoring. Without these changes, opportunities to reduce dementia risk and its associated societal and economic burden may be missed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.